Cargando…
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer
Downregulation of the PTEN tumor suppressor transcript is frequent in breast cancer and associates with poor prognosis and triple-negative breast cancer (TNBC) when comparing breast cancers to one another. Here we show that in almost all cases, when comparing breast tumors to adjacent normal ducts,...
Autores principales: | Pappas, Kyrie, Martin, Tiphaine C., Wolfe, Andrew L., Nguyen, Christie B., Su, Tao, Jin, Jian, Hibshoosh, Hanina, Parsons, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943788/ https://www.ncbi.nlm.nih.gov/pubmed/33750924 http://dx.doi.org/10.1038/s42003-021-01825-8 |
Ejemplares similares
-
PTEN and NEDD4 in Human Breast Carcinoma
por: Chen, Yilun, et al.
Publicado: (2015) -
Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer
por: She, Qing-Bai, et al.
Publicado: (2016) -
Tumor characterization and treatment monitoring of postsurgical human breast specimens using harmonic motion imaging (HMI)
por: Han, Yang, et al.
Publicado: (2016) -
EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy
por: Lui, Julian C., et al.
Publicado: (2016) -
Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population
por: Zhou, Zhengqiu, et al.
Publicado: (2019)